A report published by Oregon medical researchers, establishes that the hallucinogenic properties of magic mushrooms have the ability to effectively treat or reduce anxiety and depression.
The results on this study released on July 27 by the Psilocybin Advisory Board, which is mandated to give recommendations to the Oregon Health Authority (OHA).
This medical board was established earlier in the year after Oregon State passed the Measure 109 which legalized supervised medical use of psilocybin across the state. The board comprises of eight members in total.
The report submitted by the board took into account 600 research citations concerning psilocybin, the review captures all existing studies and medical research on the efficacy rate of psilocybin in treating mental health conditions.
In the report, the board points out that high quality phase 1 and phase 2 clinical trials suggest that psilocybin is efficacious in reducing depression and anxiety, including in life-threatening conditions.
In addition, the boards further quotes studies which suggest psilocybin can be used to help is alcohol and tobacco consumption.
Sam Chapman, who was the campaign manager for Yes on Measure 109, applauds this report as a remarkable milestone in decriminalizing psychedelics across the country.
“It’s another proof point in the growing evidence that psilocybin can be an effective treatment for healing and growth,” said Chapman.